Stay updated on Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Updated the page to Revision: v3.0.2, replacing the previous v3.0.1. The 'Back to Top' control was removed, a minor UI change.
    Difference
    0.8%
    Check dated 2025-09-13T17:46:06.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.8%
    Check dated 2025-09-06T15:33:43.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The web page has been updated to include a new facility name and location, specifically mentioning Bristol-Myers Squibb, while removing references to Mirati Therapeutics Inc. and various location details.
    Difference
    10%
    Check dated 2025-08-30T12:14:45.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.3%
    Check dated 2025-08-16T04:53:31.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.10 to v2.16.11, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-08-09T00:16:13.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    4%
    Check dated 2025-08-01T19:36:12.000Z thumbnail image

Stay in the know with updates to Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page.